Skip to main content Deutsch

News - Page 109 of 148

A new treatment option significantly reduces the risk of relapse in the case of HER2-positive breast cancer

Medicine & Science

Antibody-drug conjugate (trastuzumab emtansine) reduces the risk of relapse by 50 percent compared to standard therapy

Risk or safety: Neuronal activity in the brain permits prediction of intuitive decisions

Medicine & Science

If the activity of specific neurons remains low, a risk will be taken again at the next opportunity

FWF approves EUR 76.1 million for outstanding projects in cutting-edge research

Medicine & Science

MedUni Vienna is researching the regulation of T cell mediated immunity by histone deacetylases

WWTF-Life Sciences Call 2018: € 6.2 million for translational research in Vienna

Medicine & Science

Award-winning Viennese research teams deal with the interfaces between basic research and clinical application

7-Tesla increasingly important for therapy monitoring

University, Medicine & Science

Ten years 7-Tesla and 15 years High-Field MRI: MedUni Vienna and Vienna General Hospital among the top imaging centres in the world

Contract extension and new Chair for inter-university Messerli Research Institute

University, Medicine & Science, Organisation

Successful joint venture between Vetmeduni Vienna, MedUni Vienna and University of Vienna to continue

New hope for fish-allergy sufferers

Medicine & Science

Allergenic protein less active in cartilaginous fish

MALDI-Mass Spectrometry enables differentiation of different degrees of chemoresistance in cancer cells

Medicine & Science

Efficient analysis method examines protein patterns from extracellular vesicles of tumours cells